Do you have Type 2 Diabetes?
Mount Sinai Hospital, Leadership Sinai Centre for Diabetes
Type 2 Diabetes Mellitus (T2DM) is a chronic and progressive condition characterised by worsening glucose control over time. This process is driven by deterioration of the cells in the body that make insulin, the pancreatic beta cells. Current therapies for early type 2 diabetes can improve glucose control but they do not protect the pancreatic beta cells from deterioration. PREVAIL is a government funded clinical trial for people with early T2DM. Our aim is to investigate therapies to protect the pancreatic beta cells and slow the progression of diabetes. We are currently inviting participants to join our study.
Your Impact
Mount Sinai Hospital is researching how to protect the cells in the body that produce insulin in order to slow the progression of diabetes and ideally reverse it. We are inviting participants to join our study.
Eligibility Criteria
All genders
30 to 80 years old
Have had diabetes for 0-7 years, and take 0-2 oral medications for diabetes
Study Tasks
provide blood sample
complete questionnaires
provide blood pressure and body measurements
participate in study treatment
Ethics
This study has been approved by Mount Sinai's Research Ethics Board (MSH REB# #14-0128-A)
Keywords
Activity and Time
Health and Wellness
Clinical Trial
Weekdays
3 hour(s) per session
4 session(s)
Compensation
Do this one out of kindness
Reimbursement
parking and/or local public transportation covered, and study supplies provided
Study Address
60 Murray Street Toronto, Ontario, Canada, M5T 3L9